Academic background&position

data loading...

1. [SCIE] Safety and tolerability of first-line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma [Cancer Medicine] - 2023-08-01
2. [SCIE] Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer [CANCER RESEARCH AND TREATMENT] - 2022-07-01
3. [SCIE] Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma [AMERICAN JOURNAL OF SURGICAL PATHOLOGY] - 2022-03-01
4. [SCIE] Update of early phase clinical trials in cancer immunotherapy [BMB REPORTS] - 2021-01-01
5. [SCIE] Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer [AMERICAN JOURNAL OF CANCER RESEARCH] - 2020-09-01